Medicare Enrolled
Dr. Thomas Benvenuti, MD
Cardiovascular Disease · Newport Beach, CA
Practice pattern: Electrophysiology & Cardiac
— Practice combining electrophysiology and cardiac services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Benvenuti from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Benvenuti?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Benvenuti
Dr. Thomas Benvenuti is a cardiovascular disease specialist in Newport Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Benvenuti performed 3,940 Medicare services across 2,348 unique beneficiaries.
Between the years covered by Open Payments, Dr. Benvenuti received a total of $10,078 from 50 pharmaceutical and/or device companies across 495 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Benvenuti is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 27% volume in CA
$10,078 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,940
Medicare services
Top 27% in CA for cardiovascular disease
2,348
Unique beneficiaries
$73
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~207 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,122 | $98 | $225 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
1,004 | $11 | $75 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
275 | $6 | $22 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
272 | $164 | $525 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
190 | $100 | $200 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
152 | $41 | $75 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
150 | $75 | $300 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
149 | $46 | $95 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
117 | $42 | $76 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
89 | $51 | $300 |
| New patient office visit, complex (60-74 min) | 82 | $176 | $375 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
75 | $398 | $1,064 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
53 | $142 | $375 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
40 | $11 | $85 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
27 | $21 | $95 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
25 | $143 | $300 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
21 | $24 | $95 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
19 | $18 | $30 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
18 | $29 | $185 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
16 | $207 | $660 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
16 | $145 | $275 |
| Cardiac catheterization | 14 | $202 | $1,300 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
14 | $10 | $27 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
8.2% high complexity
13.2% medium
78.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,078
Total received (2018-2024)
Avg $1,440/year across 7 years
Top 27% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
495
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,078 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,526
2023
$2,259
2022
$1,759
2021
$830
2020
$522
2019
$1,258
2018
$924
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$296
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$243
E.R. Squibb & Sons, L.L.C.
$225
Alnylam Pharmaceuticals Inc.
$190
ShockWave Medical, Inc
$159
PFIZER INC.
$158
Janssen Pharmaceuticals, Inc
$146
Boehringer Ingelheim Pharmaceuticals, Inc.
$134
Boston Scientific Corporation
$122
AstraZeneca Pharmaceuticals LP
$117
SCPHARMACEUTICALS INC.
$98
Kiniksa Pharmaceuticals International, plc
$89
Merck Sharp & Dohme LLC
$83
Amgen Inc.
$81
SANOFI-AVENTIS U.S. LLC
$57
Impulse Dynamics (USA) Inc.
$49
Novo Nordisk Inc
$41
Recor Medical Inc
$33
ABIOMED
$32
GENZYME CORPORATION
$31
iRhythm Technologies, Inc.
$28
Abbott Laboratories
$24
ZOLL Respicardia, Inc.
$21
Esperion Therapeutics, Inc.
$19
Kestra Medical Technology Services, Inc.
$19
Bayer Healthcare Pharmaceuticals Inc.
$15
HEARTFLOW, INC.
$14
Top 3 companies account for 30.2% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$855
Novartis Pharmaceuticals Corporation
$839
Janssen Pharmaceuticals, Inc
$783
PFIZER INC.
$751
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$621
Boehringer Ingelheim Pharmaceuticals, Inc.
$541
AstraZeneca Pharmaceuticals LP
$508
E.R. Squibb & Sons, L.L.C.
$466
Alnylam Pharmaceuticals Inc.
$419
Boston Scientific Corporation
$408
Abbott Laboratories
$396
Amarin Pharma Inc.
$379
Impulse Dynamics (USA) Inc.
$311
Merck Sharp & Dohme LLC
$247
Regeneron Healthcare Solutions, Inc.
$233
HeartFlow, Inc.
$194
Kestra Medical Technology Services, Inc.
$182
Otsuka America Pharmaceutical, Inc.
$182
ShockWave Medical, Inc
$159
Actelion Pharmaceuticals US, Inc.
$149
SCPHARMACEUTICALS INC.
$122
SANOFI-AVENTIS U.S. LLC
$115
Lundbeck LLC
$106
Medtronic, Inc.
$105
CMP Pharma, Inc.
$97
Kiniksa Pharmaceuticals International, plc
$89
ABIOMED
$79
PORTOLA PHARMACEUTICALS, INC.
$66
Braemar Manufacturing, LLC
$56
iRhythm Technologies, Inc.
$53
Bardy Diagnostics, Inc.
$53
Kiniksa Pharmaceuticals, Ltd.
$50
Bayer Healthcare Pharmaceuticals Inc.
$47
Philips Electronics North America Corporation
$41
Novo Nordisk Inc
$41
Esperion Therapeutics, Inc.
$39
ZOLL Circulation Inc
$38
Recor Medical Inc
$33
GENZYME CORPORATION
$31
Baxter Healthcare
$23
CARDIVA MEDICAL, INC.
$23
Medtronic Vascular, Inc.
$22
ZOLL Respicardia, Inc.
$21
CathWorks, Inc.
$17
Allergan Inc.
$17
SANOFI PASTEUR INC.
$16
Sanofi Pasteur Inc.
$15
HEARTFLOW, INC.
$14
ARBOR PHARMACEUTICALS, INC.
$14
Bayer HealthCare Pharmaceuticals Inc.
$12
Top 3 companies account for 24.6% of all-time payments
Associated products mentioned in payments ›
(7999) SRC Undivided · AIRSUPRA · AMVUTTRA · ANDEXXA · AVEIR · Arcalyst · Assure WCD · BRILINTA · BYSTOLIC · CAMZYOS · CARDIOMEMS · CARDIVA VASCADE MVP VVCS 6-12F · CAROSPIR · CHANTIX · Cardiac Monitoring Suite · Carnation Ambulatory Monitor · Carospir · Confirm Rx · Connectivity and Remote care · CoreValve Evolut · Corlanor · ELIQUIS · ENTRESTO · EVKEEZA · Edarbi · FABRAZYME · FARXIGA · FFRangio System · FFRct · FLUZONE HIGH-DOSE · FUROSCIX · GENERAL TACHY · Hillrom - Cardiac Ambulatory Monitor · Impella · JARDIANCE · JOT DX · Kerendia · LATITUDE · LEQVIO · LINQ II · LUX-Dx Insertable Cardiac Monitor · LifeVest · MITRACLIP · MULTAQ · NEXLETOL · NORTHERA · Norliqva · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · Optimizer · Ozempic · PARADISE RENAL DENERVATION SYSTEM · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Quadra Assura CRT Defibrillator · Repatha · SAMSCA · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Temperature Management System · UPTRAVI · VERQUVO · VYNDAMAX · VYNDAQEL · Vascepa · WAINUA · WATCHMAN FLX · Wegovy · XARELTO · ZIO Patch · Zio monitor · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
249
Per 100K population
7.9
County median income
$113,702
Nearest hospital
HOAG MEMORIAL HOSPITAL PRESBYTERIAN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Benvenuti is an electrophysiology & cardiac specialist, with above-average Medicare volume (top 27% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Benvenuti experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Benvenuti performed 1,122 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Benvenuti receive payments from pharmaceutical companies?
Yes. Dr. Benvenuti received a total of $10,078 from 50 companies across 495 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Benvenuti's costs compare to other cardiologists in Newport Beach?
Dr. Benvenuti's average Medicare payment per service is $73. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Benvenuti) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Newport Beach
Browse cardiologists in Newport Beach ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Janssen Pharmaceuticals, Inc Payments to Doctors
See all physicians who received payments from Janssen Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology